0001192482-18-000013.txt : 20180104 0001192482-18-000013.hdr.sgml : 20180104 20180104204558 ACCESSION NUMBER: 0001192482-18-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180102 FILED AS OF DATE: 20180104 DATE AS OF CHANGE: 20180104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENWOOD GERALDINE CENTRAL INDEX KEY: 0001236451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 18511873 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-01-02 0001588972 Recro Pharma, Inc. REPH 0001236451 HENWOOD GERALDINE 490 LAPP ROAD MALVERN PA 19355 1 1 0 0 President and CEO Common Stock 2018-01-02 4 A 0 50000 0 A 175806 D Common Stock 50000 I By spouse Employee Stock Option (right to buy) 9.04 2018-01-02 4 A 0 100000 0 A 2028-01-02 Common Stock 100000 100000 D All shares of common stock are represented by unvested restricted stock units that will vest in four equal installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. /s/ Ryan D. Lake, Attorney-in-fact 2018-01-04